Dr. Lazar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd--Unit 85
Houston, TX 77030Phone+1 713-563-1843
Summary
- I am an academic physician focused on the genomic characteristics of cancer and using this information to better diagnose, treat and understand this disease focusing on sarcoma and melanoma. Additional areas of interest include improved understanding of checkpoint inhibitor therapy and the role of the gut microbiome in disease progression and response to therapy.
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Dermatopathology, 2003 - 2004
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2000 - 2003
- University of Texas Southwestern Medical SchoolClass of 2000
- University of Texas Southwestern Graduate School of Biomedical SciencePh.D., Pharmacology / Cell Regulation, 2000
- Austin CollegeB.A., Philosophy and Political Science, 1990
Certifications & Licensure
- TX State Medical License 2004 - 2026
- MA State Medical License 2003 - 2009
- American Board of Dermatology Dermatopathology
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Dermatopathology
Awards, Honors, & Recognition
- Distinguished Alumni Award Austin College, 2015
- Resident Council Subspecialty Award (C. Arnold) American Society of Clinical Pathology (ASCP), 2008
- Resident Council Subspecialty Award (A Galvino) American Society of Clinical Pathology (ASCP), 2007
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsAppropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of...Maxwell A Fung, Claudia I. Vidal, Eric A Armbrecht, Aleodor A. Andea, David S. Cassarino
Journal of Cutaneous Pathology. 2021-09-18 - 16 citationsImpact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms.Sarah Benton, Jeffrey Zhao, Bin Zhang, Armita Bahrami, Raymond L. Barnhill
The American Journal of Surgical Pathology. 2021-12-01 - 1594 citationsPan-cancer analysis of whole genomesPeter J. Campbell, Gad Getz, Jan O. Korbel, Joshua M. Stuart, Jennifer L. Jennings
Nature. 2020-02-06
Journal Articles
- Author Correction: Fecal Microbiota Transplantation for Refractory Immune Checkpoint Inhibitor-Associated ColitisMatthew T Campbell, Jennifer A Wargo, John R Stroehlein, Padmanee Sharma, Sumit K Subudhi, Gottumukkala S Raju, Jianjun Gao, Alexander J Lazar, Dipen M Maru, Michael T..., Nature
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Fluorescence In-situ Hybridization (FISH) is a Useful Ancillary Diagnostic Tool for Extraskeletal Myxoid ChondrosarcomaWang W-L, Mayordomo E, Czerniak B, Abruzzo LV, Lev D, Lopez-Terrada, Lazar AJ, USCAP Annual Meeting, Denver, CO, 1/1/2008
- Alveolar Soft Part Sarcoma: Review of 71 Cases Treated at a Single InstitutionLazar AJ, Kotlingham D, Lopez-Terrada, Warneke C, Lev D, USCAP Annual Meeting, San Diego, CA, 1/1/2007
- Her-2/neu Expression and Gene Amplification in Malignant and Metastasizing Skin Adnexal TumorsNash JW, Ivan D, Prieto VG, Diwan AH, Calonje E, Barrett T, Sneige N, Lyle S, Lazar AJ, USCAP Annual Meeting, Atlanta, GA, 1/1/2006
- Join now to see all
Lectures
- Pathology Response Evaluation and Guidelines for NBTXR3 Treatment in Soft Tissue SarcomaParis, France - 1/30/2015
- SC21: Cutaneous Adnexal Tumors: an UpdateBoston, MA - 1/27/2015
- Molecular Diagnostics of Melanoma and GISTBoston, MA - 1/25/2015
- Join now to see all
Other
- MelanomaSullivan R, Lazar AJ, ASCO University
https://connection.asco.org/discussion/melanoma-october-2015-molecular-oncology-tumor-boards
1/1/2015 - A Review of the WHO Classification of Tumours of Soft Tissue and Bone.Al Saanna G, Judith Bovee JVMG, Hornick JL, Lazar AJ, ESUN website
1/1/2013 - The Current State of Molecular Pathology in Diagnosing Sarcomas.Demicco EG, Lazar AJ
http://bit.ly/yqBPKm
1/1/2012 - Join now to see all
Press Mentions
- How Colorado Caught COVID: The Third WaveJune 30th, 2021
- Osteosarcoma Profiling Reveals Why Immunotherapy Remains IneffectiveFebruary 22nd, 2020
- New Rapid-Fire Method Using Pathology Images, Tumor Data May Help Guide Cancer TherapiesApril 13th, 2018
- Join now to see all
Professional Memberships
- Member
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: